Eunice Nduati/Lancet Microbe

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.Chanda C Kibengo F Mutua M Ogada F Muturi-Kioi V Akis Yildirim BM Amondi M Baines A Basajja V Borthwick N Bosire K Chambula E Chetty P Chinyenze K Chirro O Crook A De Bont J Fernandez N Ejou P Farah B Glaze M Gombe B Gumbe A Hayes P Itwi S Juma S Kabarambi A Kabengele C Kafeero P Kakande A Kanungi J Kidega W King D Mahira R Malogo R Matsoso M Michelo C Moyo A Mugaba S Mugenya I Muhumuza P Mujadidi YF Muriuki M Musale V Mutua G Muwowo M Mwale F Mwangi I Nakimbugwe M Namuyanja A Nduati E Nielsen L Nyange J Oino G Okech B Omosa-Manyonyi G Otieno D Palmer S Phiri H Ramko K Rutishauser RL Sayeed E Sajabi R Serwanga J GTWee E Wenden C Cicconi P Fast P Gilmour J Jaoko W Kaleebu P Kilembe W Kuipers H Sanders EJ Hanke T
Lancet Microbe, (2025). 6:101041